Navigation Links
Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage

Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism. While the study was done in mice, they are the first genetically engineered to develop osteoarthritis like humans, with the same genetic predisposition that makes some more likely to develop the disease, the authors said. If all goes well with a follow-up study currently underway, researchers will apply to the U.S. Food and Drug Administration for permission to begin human trials next year.

Nearly everyone aged 65 or older suffers from the pain, swelling and permanent joint damage of osteoarthritis. The most common form of arthritis, it develops over time following initial joint injuries or just as a result of aging. In the current study, researchers found that one injection of a newly designed gene therapy relieved 100 percent of osteoarthritic pain in the study model. In addition, researchers were surprised to find that the therapy also brought about a nearly 35 percent reduction in permanent structural to joints caused by round and after round of osteoarthritic inflammation.

To date, treatment of arthritis is dominated by drug treatments like non-steroidal, anti-inflammatory drugs, COX-2 inhibitors and acetominophen. Morphine and its derivatives are still in common use as well, but can depress breathing and lead to addiction. Taken together, current treatments deliver inconsistent results and new approaches are needed, researcher said. Gene therapy has been attempted in the past, but older, invasive techniques required that therapeutic genes be injected directly into nerve cells. Strong pain relief resulted, but in some cases the injections caused nerve damage.

"Our publication represents the first proof that gene therapy can work in a way that is clinically applicable," said Stephanos Kyrkanides, D.D.
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental shingles vaccine proves effective in nationwide study
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
5. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
6. Experimental RNA-based drug kills prostate cancer cells effectively and safely
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Experimental vaccine protects mice against deadly 1918 flu virus
9. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
10. Experimental vaccine given during pregnancy reduces stillbirths from common virus
11. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
Post Your Comments:
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
(Date:6/18/2013)... 2013 The herbal extract of a yellow-flowered mountain ... increase the lifespan of fruit fly populations by an ... , But it,s how Rhodiola rosea ... grabbed the attention of study leaders Mahtab Jafari and ... in a manner completely unrelated to dietary restriction and ...
(Date:6/18/2013)... internationally recognized feline experts including veterinarians and feline scientists ... Lincoln, U.K. and Dr Ilona Rodan, Director of Cat ... Society of Feline Medicine (ISFM) and the American Association ... owners and those working with cats on how to ... new guidelines appear in the Journal of Feline ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2Feline behavior experts release guidelines to improve the welfare of cats 2
... connections between nerve cells in the brain can be regulated ... from UC Davis. The research, published Feb. 27 in the ... between immunity, infectious disease and conditions such as schizophrenia or ... with changes in connectivity in the brain, said Kimberley McAllister, ...
... left us with vivid images of the grasshopper plagues ... commonly referred to as grasshoppers, the infestations were actually ... became extinct in 1902, but their cousins, grasshoppers and ... (2005 U.S. dollars) in damage to grazing lands in ...
... 25, 2011 The threat of counterfeit documents ... and optical scanners have made it easy for ... checks among many types of documents.  It has ... be able to detect fraudulent bank checks.  Additionally, ...
Cached Biology News:Immune molecule regulates brain connections 2Notre Dame research offers important clues about grasshopper population explosions 2Advanced Protection Against Document Fraud - ICAP Ocean Tomo Announces Auction of a Counterfeit Document Detection System 2Advanced Protection Against Document Fraud - ICAP Ocean Tomo Announces Auction of a Counterfeit Document Detection System 3
(Date:6/19/2013)... 2013 Express Diagnostics Int’l, Inc., manufacturer ... that it has received Class III medical device license ... DrugCheck® NxStep Onsite Drug Screen Cup in ... screening device in near-patient settings, such as physicians’ offices. ... Health Canada Class III approval for 24 different drugs ...
(Date:6/18/2013)... In support of Swiss contributions to scientific ... Switzerland in New York is pleased to welcome the ... , to Manhattan. PlanetSolar is in New York ... with scientists on board from the University of Geneva. ... on energy from the sun and eliminates the need ...
(Date:6/18/2013)... DE (PRWEB) June 18, 2013 DuPont ... to the 11th annual DuPont National AgriScience Teachers Ambassador ... Farms in Chestertown, Md. , The ... by DuPont and is a special project of the ... Association of Agricultural Educators (NAAE) . The highly ...
(Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), ... today that Mr. Jacob Ho, Acting Chief Financial Officer, ... Yang, Investor Relations Manager, are scheduled to present at ... November. Goldman Sachs China Investment Frontier ...
... Mass., Oct. 26 Idenix Pharmaceuticals, Inc. (Nasdaq: ... corporate overview at the Oppenheimer & Co. 21st Annual Healthcare ... at the Waldorf Astoria, New York City. ... be accessed under "Calendar of Events" in the Idenix Investor ...
... YORK, Oct. 26 Signal Genetics, the parent company ... company focused on oncology, today announced the formation of ... Kenneth Anderson, M.D. Director, Jerome Lipper ... Family Professor of Medicine, Harvard Medical School ...
Cached Biology Technology:Sinovac Participates in Two Investor Conferences in November 2Signal Genetics Announces Establishment of Scientific Advisory Board 2Signal Genetics Announces Establishment of Scientific Advisory Board 3